Baltimore Washington Financial Advisors Inc. Sells 571 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Baltimore Washington Financial Advisors Inc. decreased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.1% in the 3rd quarter, HoldingsChannel reports. The fund owned 26,419 shares of the healthcare conglomerate’s stock after selling 571 shares during the period. Baltimore Washington Financial Advisors Inc.’s holdings in UnitedHealth Group were worth $15,447,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Delta Financial Group Inc. increased its holdings in shares of UnitedHealth Group by 1.0% during the third quarter. Delta Financial Group Inc. now owns 1,650 shares of the healthcare conglomerate’s stock valued at $965,000 after acquiring an additional 17 shares in the last quarter. Signature Resources Capital Management LLC increased its holdings in shares of UnitedHealth Group by 40.0% during the second quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock valued at $32,000 after acquiring an additional 18 shares in the last quarter. Saxony Capital Management LLC grew its holdings in UnitedHealth Group by 3.5% during the second quarter. Saxony Capital Management LLC now owns 530 shares of the healthcare conglomerate’s stock worth $270,000 after buying an additional 18 shares in the last quarter. GoalVest Advisory LLC grew its holdings in UnitedHealth Group by 0.6% during the second quarter. GoalVest Advisory LLC now owns 3,124 shares of the healthcare conglomerate’s stock worth $1,591,000 after buying an additional 18 shares in the last quarter. Finally, Fiduciary Group LLC grew its holdings in UnitedHealth Group by 0.5% during the second quarter. Fiduciary Group LLC now owns 3,695 shares of the healthcare conglomerate’s stock worth $1,882,000 after buying an additional 18 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $590.87 on Friday. The business’s 50-day moving average price is $582.63 and its two-hundred day moving average price is $552.95. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The stock has a market cap of $543.77 billion, a P/E ratio of 38.49, a PEG ratio of 1.75 and a beta of 0.58. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The firm had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. During the same quarter last year, the firm posted $6.56 EPS. The company’s revenue was up 9.2% compared to the same quarter last year. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be issued a dividend of $2.10 per share. The ex-dividend date is Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.42%. UnitedHealth Group’s dividend payout ratio is 54.72%.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on UNH. TD Cowen upped their price target on UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a report on Friday, October 18th. HSBC downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 17th. Truist Financial reissued a “buy” rating and issued a $625.00 price objective (down previously from $640.00) on shares of UnitedHealth Group in a research report on Wednesday, October 16th. Hsbc Global Res cut UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research report on Thursday, October 17th. Finally, Bank of America cut their price objective on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a research report on Wednesday, October 16th. Four investment analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, UnitedHealth Group has a consensus rating of “Moderate Buy” and a consensus price target of $615.53.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.